The largest database of trusted experimental protocols

Multispot hiv 1 2 rapid test

Manufactured by Abbott

The Multispot HIV-1/−2 Rapid Test is a qualitative immunoassay used for the detection of antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in human serum or plasma samples.

Automatically generated - may contain errors

2 protocols using multispot hiv 1 2 rapid test

1

HIV and Syphilis Diagnostic Workflow

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were tested by 4th generation HIV immunoassay (Abbott ARCHITECT HIV Ag/Ab Combo assay), HIV-1/−2 Ab differentiation (Bio-Rad Multispot HIV-1/−2 Rapid Test) and viral load testing (Abbott ReaLTime HIV-1 assay). All HIV+ participants were tested using the Limiting Antigen Avidity (LAg) assay (Sedia™ Biosciences Corportation).11 (link) Time from test to determination of new infection occurred within 7–10 days based on test results. Samples were also tested for syphilis using Treponemal enzyme immunoassay and immunochemoluminescence (EIA) followed by quantitative RPR; if these results did not match testing was followed up via T pallidum particle agglutination (TTPA) or fluorescent treponemal antibody-absorption (TPA) test.
+ Open protocol
+ Expand
2

Determining HIV Infection Status

Check if the same lab product or an alternative is used in the 5 most similar protocols
Laboratory testing was done to determine HIV infection status (including acute infection). Replicating prior work we utilized fourth-generation HIV immunoassay (Abbott ARCHITECT HIV Ag/Ab Combo assay), HIV-1/-2 Ab differentiation (Bio-Rad Multispot HIV-1/-2 Rapid Test), and viral load testing (Abbott ReaLTime HIV-1 assay) administered to eluted dry blood spot samples.54 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!